RPS6KA1 and breast cancer: We extended the clinical implication of phospho-p90RSK expression in pre-chemotherapy core needle biopsy specimens of 112 locally advanced breast cancer patients who underwent neoadjuvant chemotherapy with anthracyclin and taxane-based regimens.